Search Results 81-90 of 16367 for Proliferation

1. Study to Evaluate CCS1477 in Haematological Malignancies - Mayo Clinic

   ... proliferation and survival. The compound causes G1 cell cycle arrest and is anti-proliferative across a broad range of haematological cell models ...

2. Mayo Clinic-led Team Identifies Master Switch for Cancer-Causing HER2 Protein

   These pairings create a kind of molecular key that opens up communication channels into the cell for stimulating proliferation and growth. When there is too ...

3. Oncology (Medical) - Clinical trials

   Onvansertib is a drug that binds to and inhibits an enzyme called PLK1, preventing cancer cell proliferation and causing cell death. DNA Methylation in ...

4. A Study of ABC294640 (Yeliva®) in the Treatment of Patients with Advanced Cholangiocarcinoma - Mayo Clinic

   ... proliferation. ABC294640 also inhibits proliferation and induces apoptosis of cholangiocarcinoma cell lines. Furthermore, in a recent Phase I trial ...

5. Breast Cancer Risk Assessment Tool for Women With Benign Breast Disease (BBD) - Mayo Clinic

   Granulomatous mastitis. close. Proliferative Disease Without Atypia (PDWA) (examples). The biopsy did not contain any of the lesions listed under AH above but ...

6. Neuroendocrine tumors - Symptoms and causes - Mayo Clinic

   https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-endocrine-tumor/carcinoid-tumor. Accessed March 16, 2025. Ki-67 proliferation index. National ...

7. Determining the Role of PTEN/AKT Signaling in Extrahepatic Cholangiocarcinoma Using a Novel Genetic Mouse Model - Mayo Clinic Research

   In specific Aim 2, we are testing whether bile salts trigger cell proliferation, inflammation and fibrosis through the PTEN-AKT signaling pathway. This study is ...

8. Mayo Clinic Brain Tumor Patient-Derived Xenograft (PDX) National Resource PDX Sample Request Form

   Media conditions that do not promote sufficient proliferation should be avoided. 2. What size flask do you want? GBM12. ☒ T75. ☐ T150. Page 3. Official ...

9. Martin E. Fernandez-Zapico, M.D. - Mayo Clinic Faculty Profiles

   ... proliferation, differentiation and apoptosis. Pancreatic cancer progression is characterized by activation of a defined profile of transcription factors ...

10. Phase 1/2 Dose Escalation Study in Patients With Relapsed or Refractory Waldenstrom's Macroglobulinemia - Mayo Clinic

    ... proliferation of cell populations responsible for the propagation of the disease. Participation eligibility. Participant eligibility includes age, gender ...